BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36974761)

  • 1. Prognostic Value of Machine-Learning-Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Shi B; Wang HY; Liu J; Cai Z; Song C; Yin D; Wang H; Dong Q; Song W; Dou KF
    J Am Heart Assoc; 2023 Apr; 12(7):e025812. PubMed ID: 36974761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
    Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China.
    Qiu M; Na K; Qi Z; Zhou H; Li P; Xu K; Wang B; Liu H; Li J; Li Y; Han Y
    Mayo Clin Proc; 2023 Jul; 98(7):1021-1032. PubMed ID: 37419570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients.
    Abu-Assi E; Raposeiras-Roubin S; Cobas-Paz R; Caneiro-Queija B; Martínez-Reglero C; Rodríguez-Rodríguez JM; Baz A; Íñiguez-Romo A
    EuroIntervention; 2018 Mar; 13(16):1914-1922. PubMed ID: 29131804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.
    Song L; Guan C; Yan H; Qiao S; Wu Y; Yuan J; Dou K; Yang Y; Dangas GD; Xu B
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):573-581. PubMed ID: 29322612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.
    Raposeiras-Roubín S; Caneiro Queija B; D'Ascenzo F; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Quadri G; Rognoni A; Boccuzzi G; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Flores Blanco P; Garay A; Varbella F; Tomassini F; Cobas Paz R; Cespón Fernández M; Muñoz Pousa I; Gallo D; Morbiducci U; Domínguez-Rodríguez A; Baz-Alonso JA; Calvo-Iglesias F; Valdés M; Cequier Á; Gaita F; Alexopoulos D; Íñiguez-Romo A; Abu-Assi E
    Rev Esp Cardiol (Engl Ed); 2019 Mar; 72(3):215-223. PubMed ID: 30029980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World.
    Yan K; Zhu P; Tang X; Li Y; Li J; Yuan D; Yang W; Yang Y; Gao R; Xu B; Yuan J; Zhao X
    J Atheroscler Thromb; 2023 Aug; 30(8):1057-1069. PubMed ID: 37258235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
    Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
    J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.
    Caneiro-Queija B; Abu-Assi E; Raposeiras-Roubín S; Manzano-Fernández S; Flores Blanco P; López-Cuenca Á; Cobas-Paz R; Gómez-Molina M; Rodríguez-Rodríguez JM; Calvo-Iglesias F; Valdés-Chávarri M; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):829-836. PubMed ID: 29656987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy.
    Choi SY; Kim MH; Cho YR; Sung Park J; Min Lee K; Park TH; Yun SC
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006837. PubMed ID: 30545256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.
    Palmerini T; Bruno AG; Gilard M; Morice MC; Valgimigli M; Montalescot G; Collet JP; Della Riva D; Bacchi-Reggiani ML; Steg PG; Diallo A; Vicaut E; Helft G; Nakamura M; Généreux P; Vahl TP; Stone GW
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007541. PubMed ID: 30871353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the REACH, PARIS, BleeMACS, and PRECISE-DAPT scores for predicting 1-year bleeding events in patients undergoing coronary drug-eluting stent implantation.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Platelets; 2022 Jul; 33(5):719-726. PubMed ID: 34634980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
    Valgimigli M; Smits PC; Frigoli E; Bongiovanni D; Tijssen J; Hovasse T; Mafragi A; Ruifrok WT; Karageorgiev D; Aminian A; Garducci S; Merkely B; Routledge H; Ando K; Diaz Fernandez JF; Cuisset T; Nesa Malik FT; Halabi M; Belle L; Din J; Beygui F; Abhyankar A; Reczuch K; Pedrazzini G; Heg D; Vranckx P;
    Eur Heart J; 2022 Sep; 43(33):3100-3114. PubMed ID: 35580836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention.
    Hara H; Takahashi K; Kogame N; Tomaniak M; Kerkmeijer LSM; Ono M; Kawashima H; Wang R; Gao C; Wykrzykowska JJ; de Winter RJ; Neumann FJ; Plante S; Lemos Neto PA; Garg S; Jüni P; Vranckx P; Windecker S; Valgimigli M; Hamm C; Steg PG; Onuma Y; Serruys PW
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009177. PubMed ID: 32838554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Platelets; 2022 Aug; 33(6):900-910. PubMed ID: 35103582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines.
    Ueki Y; Karagiannis A; Zanchin C; Zanchin T; Stortecky S; Koskinas KC; Siontis GCM; Praz F; Otsuka T; Hunziker L; Heg D; Moschovitis A; Seiler C; Billinger M; Pilgrim T; Valgimigli M; Windecker S; Räber L
    JACC Cardiovasc Interv; 2019 May; 12(9):820-830. PubMed ID: 30981574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.